Surana, who worked as an audit associate at EY in London told News18 that her company continues to position Dolo 650 as a prescription medication, while strategically transitioning Dolo 500 to the over the counter (OTC) segment.
Related Posts
Apex Panel Mulls Stricter Rules To Curb Misleading Claims By Nutraceuticals, Shifts Oversight From FSSAI | Exclusive
In February, the government formed the panel to examine the possibility of bringing nutraceuticals under the ambit of CDSCO instead of food regulator FSSAI to […]
Kota: 10-Year-Old Girl Suffers Arm Fracture After Teacher Hits Her With Stick, FIR Lodged
The girl was allegedly hit with a stick by the teacher after he asked her to roll up and fix a mat.
Parliament Today | PM Narendra Modi Talks Of New Pledges In Lok Sabha | Constitution Debate | News18
PM Modi talks of new pledges in Lok Sabha, he says says India can’t be stopped from becoming a developed nation if every Indian fulfills […]